Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Latvia

Grindeks

June 2006 | Company Spotlight

Grindeks is the largest local pharmaceutical manufacturer in Latvia and controls Estonia's Tallinn Pharmaceutical plant and Latvia's JSC Kalceks. The company develops, produces and markets final dosage form medicines and active pharmaceutical ingredients. Grindeks also manufactures and distributes products under licence for other companies.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
MoH Concerned Over Drug Prices

Industry / Latvia Latvia's Health Ministry has accused some drugmakers of selling their products at higher prices in the country than in other European Union states.
December 2007
Olainfarm To Export TB Drug To Kazakhstan

Companies / Latvia Latvian firm Olainfarm has been awarded a contract by the government of Kazakhstan to supply LVL974,000 (US$1.8mn) of PASA - sodium salt (aminosalicylic acid), a treatment for tuberculosis (TB). BMI...
February 2007
Olainfarm To Export Chemicals To Novartis UK

Companies / Latvia Latvian firm Olainfarm, in partnership with Swiss affiliate Jucker Pharma, is to supply US$1.5mn of chemical intermediates to Novartis Grimsby, a UK branch of Switzerland's largest drugmaker, Novartis....
January 2007
Free Flu Vaccinations Cancelled

Companies / Latvia Because the World Health Organisation (WHO) has lowered its risk estimates for an avian influenza epidemic, Latvia's Health Ministry has decided to end free vaccination against flu this year - and reduce...
November 2006
Latvia's Reimbursement Budget Balloons

Companies / Latvia Latvia's reimbursement budget for this year has been increased by 40% to EUR61mn (US$77mn), indicating that the country's drugs market is maturing quicker than expected. However, patients will be expected...
June 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS